MENU
+Compare
LQDA
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$10.70
Change
-$0.61 (-5.39%)
Capitalization
957.24M

LQDA Liquidia Corp Forecast, Technical & Fundamental Analysis

a developer of particle-based vaccines and therapeutics for prevention and treatment of human disease

Industry Biotechnology
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for LQDA with price predictions
Dec 17, 2024

LQDA in upward trend: price rose above 50-day moving average on December 11, 2024

LQDA moved above its 50-day moving average on December 11, 2024 date and that indicates a change from a downward trend to an upward trend. In of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where LQDA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on LQDA as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for LQDA crossed bullishly above the 50-day moving average on December 02, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LQDA advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

LQDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for LQDA moved out of overbought territory on November 29, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for LQDA turned negative on December 10, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LQDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LQDA entered a downward trend on November 25, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LQDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.658) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). LQDA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (53.476) is also within normal values, averaging (260.687).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LQDA is expected to report earnings to rise 27.17% to -38 cents per share on March 13

Liquidia Corp LQDA Stock Earnings Reports
Q4'24
Est.
$-0.38
Q3'24
Beat
by $0.07
Q2'24
Missed
by $0.03
Q1'24
Missed
by $0.23
Q4'23
Missed
by $0.19
The last earnings report on November 13 showed earnings per share of -30 cents, beating the estimate of -37 cents. With 342.25K shares outstanding, the current market capitalization sits at 957.24M.
A.I. Advisor
published General Information

General Information

a developer of particle-based vaccines and therapeutics for prevention and treatment of human disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
419 Davis Drive
Phone
+1 919 328-4400
Employees
145
Web
https://www.liquidia.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTCCX54.80N/A
N/A
MFS Technology C
STPCX11.99-0.04
-0.33%
Saratoga Technology & Comm C
PGOYX77.82-0.27
-0.35%
Putnam Large Cap Growth Y
ECFVX19.57-0.14
-0.71%
Eaton Vance Focused Value Opps C
REBYX30.02-0.33
-1.09%
Russell Inv US Small Cap Equity Y

LQDA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LQDA has been loosely correlated with ALNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LQDA jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
+2.54%
ALNY - LQDA
37%
Loosely correlated
+1.06%
AXON - LQDA
32%
Poorly correlated
-2.09%
AVXL - LQDA
30%
Poorly correlated
+0.33%
KURA - LQDA
29%
Poorly correlated
-2.36%
CRSP - LQDA
29%
Poorly correlated
+0.88%
More